|
ENST00000587762.2
|
ENST00000587762.2_6314_6334_+ |
6314–6334 |
2317.00 |
19.73 |
9.12 |
96.3 |
MIR23AHG-201
|
lncRNA
|
prostate gland
(Tissue)
|
|
ENST00000587762.2
|
ENST00000587762.2_6462_6481_+ |
6462–6481 |
1264.00 |
10.76 |
4.98 |
76.7 |
MIR23AHG-201
|
lncRNA
|
prostate gland
(Tissue)
|
|
ENST00000587762.2
|
ENST00000587762.2_6619_6638_+ |
6619–6638 |
3964.00 |
33.76 |
15.61 |
92.34 |
MIR23AHG-201
|
lncRNA
|
prostate gland
(Tissue)
|
|
ENST00000587762.2
|
ENST00000587762.2_6619_6641_+ |
6619–6641 |
1822.00 |
15.52 |
7.17 |
79.91 |
MIR23AHG-201
|
lncRNA
|
prostate gland
(Tissue)
|
|
ENST00000591345.5
|
ENST00000591345.5_1414_1429_+ |
1414–1429 |
6.00 |
6.06 |
0.02 |
100.0 |
ODAD3-204
|
nonsense mediated decay
|
prostate gland
(Tissue)
|
|
ENST00000592790.1
|
ENST00000592790.1_3381_3401_+ |
3381–3401 |
865.00 |
1.66 |
3.41 |
100.0 |
VMP1-217
|
retained intron
|
prostate gland
(Tissue)
|
|
ENST00000592790.1
|
ENST00000592790.1_3343_3402_+ |
3343–3402 |
126.00 |
0.24 |
0.50 |
100.0 |
VMP1-217
|
retained intron
|
prostate gland
(Tissue)
|
|
ENST00000592790.1
|
ENST00000592790.1_3343_3366_+ |
3343–3366 |
32579.00 |
62.55 |
128.29 |
69.94 |
VMP1-217
|
retained intron
|
prostate gland
(Tissue)
|
|
ENST00000595794.5
|
ENST00000595794.5_236_279_+ |
236–279 |
3338.00 |
0.14 |
13.14 |
100.0 |
C19orf48P-203
|
retained intron
|
prostate gland
(Tissue)
|
|
ENST00000595794.5
|
ENST00000595794.5_236_318_+ |
236–318 |
1843480.59 |
75.31 |
7259.11 |
79.52 |
C19orf48P-203
|
retained intron
|
prostate gland
(Tissue)
|
|
ENST00000595794.5
|
ENST00000595794.5_236_320_+ |
236–320 |
493599.94 |
20.17 |
1943.66 |
20.5 |
C19orf48P-203
|
retained intron
|
prostate gland
(Tissue)
|
|
ENST00000595794.5
|
ENST00000595794.5_236_330_+ |
236–330 |
16031.00 |
0.65 |
63.13 |
90.67 |
C19orf48P-203
|
retained intron
|
prostate gland
(Tissue)
|
|
ENST00000595794.5
|
ENST00000595794.5_236_276_+ |
236–276 |
289.00 |
0.01 |
1.14 |
100.0 |
C19orf48P-203
|
retained intron
|
prostate gland
(Tissue)
|
|
ENST00000595794.5
|
ENST00000595794.5_230_318_+ |
230–318 |
34.00 |
0.00 |
0.13 |
100.0 |
C19orf48P-203
|
retained intron
|
prostate gland
(Tissue)
|
|
ENST00000600027.5
|
ENST00000600027.5_434_519_+ |
434–519 |
46.00 |
5.53 |
0.18 |
100.0 |
RPS11-206
|
retained intron
|
prostate gland
(Tissue)
|
|
ENST00000600027.5
|
ENST00000600027.5_441_519_+ |
441–519 |
633.00 |
76.08 |
2.49 |
100.0 |
RPS11-206
|
retained intron
|
prostate gland
(Tissue)
|
|
ENST00000602315.3
|
ENST00000602315.3_752_771_+ |
752–771 |
5391858.00 |
74.81 |
21231.64 |
76.27 |
CARMN-209
|
lncRNA
|
prostate gland
(Tissue)
|
|
ENST00000602478.2
|
ENST00000602478.2_671_758_+ |
671–758 |
295.00 |
31.15 |
1.16 |
100.0 |
ENST00000602478
|
lncRNA
|
prostate gland
(Tissue)
|
|
ENST00000604535.1
|
ENST00000604535.1_1396_1410_+ |
1396–1410 |
621.00 |
60.59 |
2.45 |
100.0 |
PPFIA1P1-201
|
processed pseudogene
|
prostate gland
(Tissue)
|
|
ENST00000606412.1
|
ENST00000606412.1_4_67_+ |
4–67 |
377.00 |
21.89 |
1.48 |
100.0 |
SNORD114-21-201
|
snoRNA
|
prostate gland
(Tissue)
|
|
ENST00000606412.1
|
ENST00000606412.1_35_67_+ |
35–67 |
1032.00 |
59.93 |
4.06 |
100.0 |
SNORD114-21-201
|
snoRNA
|
prostate gland
(Tissue)
|
|
ENST00000606510.1
|
ENST00000606510.1_2_82_+ |
2–82 |
138.00 |
43.53 |
0.54 |
100.0 |
SNORD115-40-201
|
snoRNA
|
prostate gland
(Tissue)
|
|
ENST00000606724.1
|
ENST00000606724.1_22_43_+ |
22–43 |
11090.00 |
97.77 |
43.67 |
100.0 |
MIR98-201
|
miRNA
|
prostate gland
(Tissue)
|
|
ENST00000607261.1
|
ENST00000607261.1_3_73_+ |
3–73 |
721.00 |
92.55 |
2.84 |
100.0 |
SNORD113-5-201
|
snoRNA
|
prostate gland
(Tissue)
|
|
ENST00000607334.3
|
ENST00000607334.3_14_34_+ |
14–34 |
132.00 |
83.54 |
0.52 |
100.0 |
MIR15A-201
|
miRNA
|
prostate gland
(Tissue)
|